International delivery: Countries we currently deliver to include: Australia, Austria, Bahrain, Belgium, Bulgaria, Canada, China, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Guernsey, Hong Kong SAR China, Hungary, Ireland, India, Isle of Man, Italy, Japan, Jersey, Latvia, Lithuania, Luxembourg, Malta, Malaysia, Netherlands, New Zealand, Norway, Oman, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovakia, Slovenia, South Africa, Sweden, Switzerland, Taiwan, United Arab Emirates
In March 2025, Roche entered into an outstanding licensing agreement and collaboration with Zealand Pharma for co-commercializing and co-developing petrelintide as a standalone therapy and a fixed-dose combination with Roches lead incretin asset CT-388
It is not the same as an approved medicine, and the current safety picture is still developing through clinical trials
It is a well-researched nutrient for maintaining membrane stability, cerebral blood flow, and the production of nerve growth factor
It's a convenient pill that fits into any schedule, whether taken with or without food